Interestingly, sulforaphane treatment overcomes this resistance in bladder cancer cells by elevating ROS production, cleaved PARP, cleaved Bid and death receptor 5 (DR5), thereby leading to mitochondrial membrane potential (ΔΨm) loss and induction of apoptosis [70]. The gene discussed is TNFRSF10B; the disease is urinary bladder carcinoma.